P-glycoprotein expression in Helicobacter pylori-positive patients

The influence of MDR1 C3435T polymorphism

Marhanis Salihah Omar, Andrew Crowe, Richard Parsons, Hooi Ee, Chin Yen Tay, Jeffery Hughes

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: The aim of this study was to determine whether the presence of Helicobacter pylori (H. pylori) infection and multidrug resistance protein 1 (MDR1) C3435T polymorphism had an influence on P-glycoprotein (P-gp) expression in the upper gastrointestinal tract. Methods: A total of 76 patients who underwent upper gastroendoscopy at Sir Charles Gairdner Hospital in Western Australia from October 2010 to July 2011 were enrolled in the study. Antral and duodenal biopsies were collected for P-gp examination. Blood samples were taken and analyzed for MDR1 C3435T polymorphism. H.pylori infection status was confirmed by culture and polymerase chain reaction. Results: A significant difference was found in P-gp expression between H.pylori-positive and H.pylori-negative patients (P=0.028). For the MDR1 C3435T polymorphism, the TT genotype had a significantly lower P-gp expression compared with the CC genotype in antral specimens (P=0.041). The homozygous TT genotype with H.pylori infection was also significantly different in P-gp expression compared with H.pylori-negative patients (P=0.029). Conclusions: P-gp expression in the upper gastrointestinal tract is associated with H.pylori infection, and the TT genotype appeared to be associated with lower P-gp expression than the CC genotype in the stomach.

Original languageEnglish
Pages (from-to)414-420
Number of pages7
JournalJournal of Digestive Diseases
Volume13
Issue number8
DOIs
Publication statusPublished - Aug 2012
Externally publishedYes

Fingerprint

P-Glycoprotein
Helicobacter pylori
Pylorus
Genotype
Upper Gastrointestinal Tract
Infection
Western Australia
Helicobacter Infections
Stomach
Biopsy
Polymerase Chain Reaction

Keywords

  • Helicobacter pylori
  • Multidrug resistance
  • P-glycoprotein
  • Peptic ulcer disease
  • Single base polymorphism

ASJC Scopus subject areas

  • Gastroenterology

Cite this

P-glycoprotein expression in Helicobacter pylori-positive patients : The influence of MDR1 C3435T polymorphism. / Omar, Marhanis Salihah; Crowe, Andrew; Parsons, Richard; Ee, Hooi; Tay, Chin Yen; Hughes, Jeffery.

In: Journal of Digestive Diseases, Vol. 13, No. 8, 08.2012, p. 414-420.

Research output: Contribution to journalArticle

Omar, Marhanis Salihah ; Crowe, Andrew ; Parsons, Richard ; Ee, Hooi ; Tay, Chin Yen ; Hughes, Jeffery. / P-glycoprotein expression in Helicobacter pylori-positive patients : The influence of MDR1 C3435T polymorphism. In: Journal of Digestive Diseases. 2012 ; Vol. 13, No. 8. pp. 414-420.
@article{1232dcd464b84228aaf4773e44f878ac,
title = "P-glycoprotein expression in Helicobacter pylori-positive patients: The influence of MDR1 C3435T polymorphism",
abstract = "Objective: The aim of this study was to determine whether the presence of Helicobacter pylori (H. pylori) infection and multidrug resistance protein 1 (MDR1) C3435T polymorphism had an influence on P-glycoprotein (P-gp) expression in the upper gastrointestinal tract. Methods: A total of 76 patients who underwent upper gastroendoscopy at Sir Charles Gairdner Hospital in Western Australia from October 2010 to July 2011 were enrolled in the study. Antral and duodenal biopsies were collected for P-gp examination. Blood samples were taken and analyzed for MDR1 C3435T polymorphism. H.pylori infection status was confirmed by culture and polymerase chain reaction. Results: A significant difference was found in P-gp expression between H.pylori-positive and H.pylori-negative patients (P=0.028). For the MDR1 C3435T polymorphism, the TT genotype had a significantly lower P-gp expression compared with the CC genotype in antral specimens (P=0.041). The homozygous TT genotype with H.pylori infection was also significantly different in P-gp expression compared with H.pylori-negative patients (P=0.029). Conclusions: P-gp expression in the upper gastrointestinal tract is associated with H.pylori infection, and the TT genotype appeared to be associated with lower P-gp expression than the CC genotype in the stomach.",
keywords = "Helicobacter pylori, Multidrug resistance, P-glycoprotein, Peptic ulcer disease, Single base polymorphism",
author = "Omar, {Marhanis Salihah} and Andrew Crowe and Richard Parsons and Hooi Ee and Tay, {Chin Yen} and Jeffery Hughes",
year = "2012",
month = "8",
doi = "10.1111/j.1751-2980.2012.00606.x",
language = "English",
volume = "13",
pages = "414--420",
journal = "Journal of Digestive Diseases",
issn = "1751-2972",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - P-glycoprotein expression in Helicobacter pylori-positive patients

T2 - The influence of MDR1 C3435T polymorphism

AU - Omar, Marhanis Salihah

AU - Crowe, Andrew

AU - Parsons, Richard

AU - Ee, Hooi

AU - Tay, Chin Yen

AU - Hughes, Jeffery

PY - 2012/8

Y1 - 2012/8

N2 - Objective: The aim of this study was to determine whether the presence of Helicobacter pylori (H. pylori) infection and multidrug resistance protein 1 (MDR1) C3435T polymorphism had an influence on P-glycoprotein (P-gp) expression in the upper gastrointestinal tract. Methods: A total of 76 patients who underwent upper gastroendoscopy at Sir Charles Gairdner Hospital in Western Australia from October 2010 to July 2011 were enrolled in the study. Antral and duodenal biopsies were collected for P-gp examination. Blood samples were taken and analyzed for MDR1 C3435T polymorphism. H.pylori infection status was confirmed by culture and polymerase chain reaction. Results: A significant difference was found in P-gp expression between H.pylori-positive and H.pylori-negative patients (P=0.028). For the MDR1 C3435T polymorphism, the TT genotype had a significantly lower P-gp expression compared with the CC genotype in antral specimens (P=0.041). The homozygous TT genotype with H.pylori infection was also significantly different in P-gp expression compared with H.pylori-negative patients (P=0.029). Conclusions: P-gp expression in the upper gastrointestinal tract is associated with H.pylori infection, and the TT genotype appeared to be associated with lower P-gp expression than the CC genotype in the stomach.

AB - Objective: The aim of this study was to determine whether the presence of Helicobacter pylori (H. pylori) infection and multidrug resistance protein 1 (MDR1) C3435T polymorphism had an influence on P-glycoprotein (P-gp) expression in the upper gastrointestinal tract. Methods: A total of 76 patients who underwent upper gastroendoscopy at Sir Charles Gairdner Hospital in Western Australia from October 2010 to July 2011 were enrolled in the study. Antral and duodenal biopsies were collected for P-gp examination. Blood samples were taken and analyzed for MDR1 C3435T polymorphism. H.pylori infection status was confirmed by culture and polymerase chain reaction. Results: A significant difference was found in P-gp expression between H.pylori-positive and H.pylori-negative patients (P=0.028). For the MDR1 C3435T polymorphism, the TT genotype had a significantly lower P-gp expression compared with the CC genotype in antral specimens (P=0.041). The homozygous TT genotype with H.pylori infection was also significantly different in P-gp expression compared with H.pylori-negative patients (P=0.029). Conclusions: P-gp expression in the upper gastrointestinal tract is associated with H.pylori infection, and the TT genotype appeared to be associated with lower P-gp expression than the CC genotype in the stomach.

KW - Helicobacter pylori

KW - Multidrug resistance

KW - P-glycoprotein

KW - Peptic ulcer disease

KW - Single base polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84863859816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863859816&partnerID=8YFLogxK

U2 - 10.1111/j.1751-2980.2012.00606.x

DO - 10.1111/j.1751-2980.2012.00606.x

M3 - Article

VL - 13

SP - 414

EP - 420

JO - Journal of Digestive Diseases

JF - Journal of Digestive Diseases

SN - 1751-2972

IS - 8

ER -